Connecticut Innovations
Overview
Connecticut Innovations (CI) is Connecticut's strategic venture capital arm and is the leading source of financing and ongoing support for innovative, growing companies . By offering equity and debt investments, strategic guidance, and introductions to valuable partners, CI helps promising businesses to thrive . CI invests in early-stage companies, typically between $500,000 and $1,000,000 per round, with a maximum of $7 million in any one company .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rejuvenate Bio | Jun 2026 | Early Funding | Co-investor |
| Cypher AI | May 2026 | Seed | Co-investor |
| P2 Science Inc. | May 2026 | Growth Equity | Co-investor |
| Neurosoft Bioelectronics | May 2026 | Seed | Co-investor |
| Vortex Imaging | May 2026 | Early Funding | Co-investor |
Key People
Tim Howe
Venture Partner, Executive In Residence, Managing Partner
David Wurzer
Venture Partner
Michael Sheldon
Venture Partner
Cynthia Malkin
Commercial Investment Partner Senior Partner, Audit And Risk Committee
Marina D.
Talent Acquisition Partner
Danny Qiao
Venture Investing
Ayden Cinel
Venture Capital Intern
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
